These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19036913)

  • 1. Optimal designs for empirical bayes estimators of individual linear and quadratic growth curves in linear mixed models.
    Candel MJ
    Stat Methods Med Res; 2009 Aug; 18(4):397-419. PubMed ID: 19036913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-optimal cohort designs for linear mixed-effects models.
    Tekle FB; Tan FE; Berger MP
    Stat Med; 2008 Jun; 27(14):2586-600. PubMed ID: 17726724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal designs for clinical trials with second-order polynomial treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2007 Dec; 16(6):523-37. PubMed ID: 17698939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal time-points in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Med; 2005 Dec; 24(24):3743-56. PubMed ID: 16320272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous estimation of parameters in different linear models and applications to biometric problems.
    Rao CR
    Biometrics; 1975 Jun; 31(2):545-54. PubMed ID: 1174618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models for empirical Bayes estimators of longitudinal CD4 counts.
    LaValley MP; DeGruttola V
    Stat Med; 1996 Nov 15-30; 15(21-22):2289-305; discussion 2337-40. PubMed ID: 8931202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal designs for estimating and testing interaction among multiple loci in complex traits by a Gibbs sampler.
    Lee C; Kim Y
    Genomics; 2008 Dec; 92(6):446-51. PubMed ID: 18786631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dropout on the efficiency of D-optimal designs of linear mixed models.
    Ortega-Azurduy SA; Tan FE; Berger MP
    Stat Med; 2008 Jun; 27(14):2601-17. PubMed ID: 17943923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertainty.
    Dokoumetzidis A; Aarons L
    J Biopharm Stat; 2007; 17(5):851-67. PubMed ID: 17885870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossover designs with correlated observations.
    Donev AN
    J Biopharm Stat; 1998 May; 8(2):249-62. PubMed ID: 9598421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear mixed-effects modeling: individualization and prediction.
    Olofsen E; Dinges DF; Van Dongen HP
    Aviat Space Environ Med; 2004 Mar; 75(3 Suppl):A134-40. PubMed ID: 15018275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too many cohorts and repeated measurements are a waste of resources.
    Tekle FB; Tan FE; Berger MP
    J Clin Epidemiol; 2011 Dec; 64(12):1383-90. PubMed ID: 21592727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian covariance selection in generalized linear mixed models.
    Cai B; Dunson DB
    Biometrics; 2006 Jun; 62(2):446-57. PubMed ID: 16918908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring explained variation in linear mixed effects models.
    Xu R
    Stat Med; 2003 Nov; 22(22):3527-41. PubMed ID: 14601017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of repeated-measures analysis of variance and hierarchical linear model in nursing research.
    Shin JH
    Nurs Res; 2009; 58(3):211-7. PubMed ID: 19448525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal designs for Michaelis-Menten kinetic studies.
    Matthews JN; Allcock GC
    Stat Med; 2004 Feb; 23(3):477-91. PubMed ID: 14748040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of carryover effects on the variances of estimators of treatment differences in crossover designs.
    Ozan MO; Stufken J
    Stat Med; 2010 Oct; 29(24):2480-5. PubMed ID: 20683837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilevel mixture cure models with random effects.
    Lai X; Yau KK
    Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.